<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T01:46:00Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:9648784" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:9648784</identifier>
        <datestamp>2022-11-15</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS One</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-title-group>
                <journal-title>PLOS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC9648784</article-id>
              <article-id pub-id-type="pmcid">PMC9648784</article-id>
              <article-id pub-id-type="pmc-uid">9648784</article-id>
              <article-id pub-id-type="pmid">36355827</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0277009</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-22-04797</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Health Care</subject>
                    <subj-group>
                      <subject>Caregivers</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Psychological Stress</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Psychological Stress</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Psychology</subject>
                    <subj-group>
                      <subject>Psychological Stress</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Proteins</subject>
                      <subj-group>
                        <subject>Lipoproteins</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Medical Risk Factors</subject>
                      <subj-group>
                        <subject>Cancer Risk Factors</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Cancer Risk Factors</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Biology and Life Sciences</subject>
                  <subj-group>
                    <subject>Biochemistry</subject>
                    <subj-group>
                      <subject>Biomarkers</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Surgical and Invasive Medical Procedures</subject>
                    <subj-group>
                      <subject>Blood and Lymphatic System Procedures</subject>
                      <subj-group>
                        <subject>Stem Cell Transplantation</subject>
                        <subj-group>
                          <subject>Hematopoietic Stem Cell Transplantation</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Surgical and Invasive Medical Procedures</subject>
                    <subj-group>
                      <subject>Transplantation</subject>
                      <subj-group>
                        <subject>Cell Transplantation</subject>
                        <subj-group>
                          <subject>Stem Cell Transplantation</subject>
                          <subj-group>
                            <subject>Hematopoietic Stem Cell Transplantation</subject>
                          </subj-group>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and analysis methods</subject>
                  <subj-group>
                    <subject>Spectrum analysis techniques</subject>
                    <subj-group>
                      <subject>NMR spectroscopy</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Mental Health and Psychiatry</subject>
                    <subj-group>
                      <subject>Mood Disorders</subject>
                      <subj-group>
                        <subject>Depression</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Effects of a yoga-based stress reduction intervention on stress, psychological outcomes and cardiometabolic biomarkers in cancer caregivers: A randomized controlled trial</article-title>
                <alt-title alt-title-type="running-head">Stress reduction intervention in cancer caregivers</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2086-993X</contrib-id>
                  <name>
                    <surname>Lee</surname>
                    <given-names>Lena J.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                  <xref rid="cor001" ref-type="corresp">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shamburek</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/software/">Software</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3988-7492</contrib-id>
                  <name>
                    <surname>Son</surname>
                    <given-names>Hyojin</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wallen</surname>
                    <given-names>Gwenyth R.</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cox</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Flynn</surname>
                    <given-names>Sharon</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Yang</surname>
                    <given-names>Li</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-original-draft/">Writing – original draft</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bevans</surname>
                    <given-names>Margaret</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff002" ref-type="aff">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7909-0293</contrib-id>
                  <name>
                    <surname>Wehrlen</surname>
                    <given-names>Leslie</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
                  <xref rid="aff003" ref-type="aff">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ross</surname>
                    <given-names>Alyson</given-names>
                  </name>
                  <role content-type="http://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
                  <role content-type="http://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
                  <role content-type="http://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role>
                  <role content-type="http://credit.niso.org/contributor-roles/methodology/">Methodology</role>
                  <role content-type="http://credit.niso.org/contributor-roles/supervision/">Supervision</role>
                  <role content-type="http://credit.niso.org/contributor-roles/writing-review-editing/">Writing – review &amp; editing</role>
                  <xref rid="aff001" ref-type="aff">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Translational Biobehavioral and Health Disparities Branch, National Institutes of Health (NIH) Clinical Center, Bethesda, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>National Heart, Lung, and Blood Institute, NIH, Bethesda, Maryland, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Office of Research Support &amp; Compliance, NIH Clinical Center, Bethesda, Maryland, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Vassalle</surname>
                    <given-names>Cristina</given-names>
                  </name>
                  <role>Editor</role>
                  <xref rid="edit1" ref-type="aff"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Fondazione Toscana Gabriele Monasterio, ITALY</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>jumin.park@nih.gov</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>10</day>
                <month>11</month>
                <year>2022</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2022</year>
              </pub-date>
              <volume>17</volume>
              <issue>11</issue>
              <elocation-id>e0277009</elocation-id>
              <history>
                <date date-type="received">
                  <day>23</day>
                  <month>2</month>
                  <year>2022</year>
                </date>
                <date date-type="accepted">
                  <day>18</day>
                  <month>10</month>
                  <year>2022</year>
                </date>
              </history>
              <permissions>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="cc0license">https://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref>
                  <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0277009.pdf"/>
              <abstract>
                <p>Caregiving stress is a risk factor for cardiometabolic disease. Therefore, integrating cardiometabolic biomarkers into caregiving research provides a more comprehensive assessment of an individual’s health and response to an intervention. The objective of this study was to examine the effects of a yoga-based stress reduction intervention on stress, psychological outcomes, and cardiometabolic biomarkers in cancer caregivers. This prospective randomized controlled trial enrolled family caregivers of adult patients who underwent an allogeneic HSCT at the National Institutes of Health (NIH) Clinical Center. All subjects received usual care education. Participants in the intervention group received an Iyengar yoga intervention self-administered over six weeks using an audio recording file. The primary outcome was perceived stress (measured using the NIH toolbox Perceived Stress). The secondary outcomes were psychological factors (depression and anxiety measured using PROMIS<sup>®</sup> Depression and Anxiety), and cardiometabolic biomarkers measured by nuclear magnetic resonance spectroscopy. A total of 50 family caregivers (mean [SD] age, 44.9 [15.2] years; 42 [84.0%] women) were randomized, 25 to the intervention group and 25 to the control group. No group differences were noted in stress, depression, and anxiety. Significant interaction effects between group and time were found in large TRL-P (<italic toggle="yes">F</italic>(1,43) = 10.16, <italic toggle="yes">p</italic> = 0.003) and LP-IR (<italic toggle="yes">F</italic>(1,42) = 4.28, <italic toggle="yes">p</italic> = 0.045). Post-hoc analyses revealed that the levels of large TRL-P (mean difference = 1.68, CI = [0.86, 2.51], <italic toggle="yes">p&lt;</italic> .001) and LP-IR (mean difference = 5.67, CI = [1.15, 10.18], <italic toggle="yes">p =</italic> 0.015) significantly increased over time in the control group but while remained stable in the intervention group (mean difference = -0.15, CI = [-0.96, 0.66], <italic toggle="yes">p</italic> = 0.718; mean difference = -0.81, CI = [-5.22, 3.61], <italic toggle="yes">p</italic> = 0.714, respectively). Even when perceptions of psychological distress remain unchanged, incorporating gentle yoga poses and breathing exercises may reduce the risk of cardiometabolic disease in caregivers by inhibiting the development of insulin resistance. Standard lipids of cardiometabolic risk do not appear to be robust enough to detect short-term early changes of cardiometabolic risk in caregivers.</p>
                <p><bold>Trial registration</bold>: ClinicalTrials.gov Identifier: <ext-link xlink:href="https://clinicaltrials.gov/ct2/show/NCT02257853" ext-link-type="uri">NCT02257853</ext-link>.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000098</institution-id>
                      <institution>NIH Clinical Center</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>NCT#02257853</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-2086-993X</contrib-id>
                    <name>
                      <surname>Lee</surname>
                      <given-names>Lena J.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>This research was supported by the Intramural Research Program at the National Institutes of Health, Clinical Center (grant number NCT#02257853). All authors from the NIH Clinical Center received support for this study.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="3"/>
                <page-count count="14"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>All relevant data are within the paper and its <xref rid="sec016" ref-type="sec">Supporting information</xref> files.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>All relevant data are within the paper and its <xref rid="sec016" ref-type="sec">Supporting information</xref> files.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Caring for a family member with cancer, the fourth main reason for caregiving in the U.S., is intense and challenging [<xref rid="pone.0277009.ref001" ref-type="bibr">1</xref>, <xref rid="pone.0277009.ref002" ref-type="bibr">2</xref>]. Among different types of cancer treatment, hematopoietic stem cell transplantation (HSCT), especially allogeneic, is a risky procedure that may cause serious early and late effects including graft versus host disease and cytopenia [<xref rid="pone.0277009.ref003" ref-type="bibr">3</xref>]. Caring for a HSCT recipient is accepted as burdensome, considering that the recipient needs extensive support [<xref rid="pone.0277009.ref004" ref-type="bibr">4</xref>, <xref rid="pone.0277009.ref005" ref-type="bibr">5</xref>]. HSCT caregivers often experience high levels of stress and symptoms such as depression and anxiety due to their caregiving burden [<xref rid="pone.0277009.ref006" ref-type="bibr">6</xref>, <xref rid="pone.0277009.ref007" ref-type="bibr">7</xref>]. Unmanaged stress and symptoms may increase the risk of developing cardiometabolic disease such as type 2 diabetes (T2D) and coronary artery disease in these caregivers [<xref rid="pone.0277009.ref008" ref-type="bibr">8</xref>–<xref rid="pone.0277009.ref011" ref-type="bibr">11</xref>].</p>
              <p>Many of the intervention studies to relieve stress and symptoms in family caregivers of people with cancer took mindfulness approaches, often including yoga, breathing exercise, and meditation as components of the intervention programs [<xref rid="pone.0277009.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0277009.ref015" ref-type="bibr">15</xref>]. These studies have shown that mindfulness-based interventions are effective in improving multiple symptoms (e.g., anxiety, depression, fatigue, sleep disturbance) and mental health in cancer caregivers [<xref rid="pone.0277009.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0277009.ref015" ref-type="bibr">15</xref>]. However, such intervention studies in HSCT caregivers have been lacking. Furthermore, those studies have relied heavily on self-reported outcomes to evaluate the effects of the interventions, while physiological responses have been rarely included as outcomes. Specifically, there is a growing body of evidence that caregiving stress is a risk factor for the development of cardiometabolic disease [<xref rid="pone.0277009.ref008" ref-type="bibr">8</xref>, <xref rid="pone.0277009.ref016" ref-type="bibr">16</xref>]; however, intervention studies focusing on assessing biomarkers of cardiometabolic function in the caregiver population are lacking.</p>
              <p>Recent evidence has suggested incorporating a serum lipoprotein particle profile assessed via nuclear magnetic resonance (NMR) spectroscopy in order to precisely identify lipid-associated cardiometabolic risk because standard lipids can vary greatly in cholesterol content (i.e., particle concentration and size) among individuals [<xref rid="pone.0277009.ref017" ref-type="bibr">17</xref>, <xref rid="pone.0277009.ref018" ref-type="bibr">18</xref>]. This approach measures particle concentrations and sizes of all lipoprotein classes (triglyceride-rich lipoprotein particle [TRL-P], low-density lipoprotein particle [LDL-P], and high-density lipoprotein particle [HDL-P]) and particle concentrations of lipoprotein subclasses (e.g., large, medium, small) [<xref rid="pone.0277009.ref017" ref-type="bibr">17</xref>]. Evidence has been accumulating, suggesting that NMR lipoprotein particle concentration and size may be sensitive enough to detect early signs of cardiometabolic risk [<xref rid="pone.0277009.ref017" ref-type="bibr">17</xref>–<xref rid="pone.0277009.ref020" ref-type="bibr">20</xref>]. However, to date, only two studies have demonstrated the superiority of NMR lipoprotein particle profile analysis in detecting early changes in cardiometabolic health in cancer caregivers [<xref rid="pone.0277009.ref010" ref-type="bibr">10</xref>, <xref rid="pone.0277009.ref021" ref-type="bibr">21</xref>]. Furthermore, no published studies have examined whether yoga designed to decrease caregivers’ stress results in changes in cardiometabolic health measured by NMR lipoprotein particle profiles. Expanding the scientific research of lipoprotein particle profiles in caregivers will contribute to understanding the impact of caregiving stress on the caregivers’ cardiometabolic health and enhance our ability to evaluate interventions.</p>
              <p>To reduce perceived stress, stress-related symptoms, and cardiometabolic risk in HSCT caregivers, we developed a six-week yoga-based stress reduction intervention. We assessed the effects of the intervention on the following outcomes: perceived stress and psychological outcomes (depression, anxiety) using self-reported measures; and cardiometabolic risk using NMR lipoprotein particle profile analysis.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Methods</title>
              <sec id="sec003">
                <title>Study design and participants</title>
                <p>A prospective randomized controlled trial (RCT) design was used to examine the effectiveness of a six-week yoga-based stress reduction intervention in family caregivers of adult patients who underwent an allogeneic HSCT at the National Institutes of Health (NIH) Clinical Center (NCT#02257853). This study followed the Consolidated Standards of Reporting Trials (CONSORT) reporting guideline for RCTs. Participants were recruited between January 2015 and February 2019. Caregivers were eligible to participate in the study if they (1) were at least 18 years old; (2) were an active caregiver for a patient undergoing the 1<sup>st</sup> allogeneic HSCT; (3) were able to read and speak English; (4) were able to lift arms over head without pain; and (5) were able to sit and stand from a seated position unassisted. This study was approved by the National Heart, Lung, and Blood Institute intramural Institutional Review Board. Written informed consent was obtained from all participants prior to initiating any study procedures.</p>
              </sec>
              <sec id="sec004">
                <title>Intervention details</title>
                <p>Based on prior research suggesting that cancer caregivers are less likely to participate in health-promoting behaviors that require them to leave the presence of the care recipient [<xref rid="pone.0277009.ref022" ref-type="bibr">22</xref>–<xref rid="pone.0277009.ref024" ref-type="bibr">24</xref>], we sought to develop a brief yoga intervention that could be performed anywhere without yoga props or special equipment. The six-week length of the intervention, as well as the 20-minute time of the audio file, was selected based upon the length of similar interventions in cancer caregiver populations, with interventions ranging between six to eight weeks [<xref rid="pone.0277009.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0277009.ref015" ref-type="bibr">15</xref>]. We worked with a certified Advanced Iyengar yoga instructor with experience in the therapeutic use of yoga as well as extensive experience in developing audio yoga classes to develop the intervention. Iyengar yoga utilizes highly standardized teaching methods, and is the yoga style most often used in RCTs [<xref rid="pone.0277009.ref025" ref-type="bibr">25</xref>]. The intervention consisted of approximately ten minutes of standing poses at the wall (urdhva hastasana, adho mukha svanasana) and very gentle seated backbends and twists, followed by ten minutes of seated ujjayi pranayama (breath awareness) and seated savasana (relaxation pose). To ensure that participants could safely complete the intervention, the intervention participants were instructed individually on performance of every pose, and they were required to return demonstrate proper and safe performance of the poses. Intervention participants were asked to contact study staff immediately should they experience any discomfort or injury.</p>
              </sec>
              <sec id="sec005">
                <title>Allocation, randomization, and details of group assignment</title>
                <p>After study enrollment, the study statistician randomized participants to either the control or the intervention group using a permuted block randomization with allocation ratio of 1:1. All participants received usual care education, which includes transplant specific information for the recipient and the caregiver, as well as written and online caregiver resources. All participants met 1:1 at the baseline clinic visit with a study investigator to review the usual care education materials. In addition, participants in the intervention group received the audio file intervention, a pamphlet containing pictures of the proper performance of the poses, and a practice diary to record daily practice. The intervention participants were asked to practice daily and to record their practice in the practice diary.</p>
              </sec>
              <sec id="sec006">
                <title>Outcome measures</title>
                <sec id="sec007">
                  <title>Primary outcome</title>
                  <p><italic toggle="yes">Perceived stress</italic>. The NIH toolbox was used to collect measures of perceived stress (10-item fixed form), using a 5-point Likert scale ranging from 1 to 5, with higher scores indicative of higher levels of perceived stress. Scores 1 standard deviation (SD) or more below the mean (T-score ≤ 40) indicate low levels of perceived stress and scores 1 SD or more above the mean (T-score ≥ 60) indicate high levels of perceived stress [<xref rid="pone.0277009.ref026" ref-type="bibr">26</xref>, <xref rid="pone.0277009.ref027" ref-type="bibr">27</xref>].</p>
                </sec>
                <sec id="sec008">
                  <title>Secondary outcomes</title>
                  <p><italic toggle="yes">Depression and anxiety</italic>. The Patient-Reported Outcomes Measurement Information System (PROMIS<sup>®</sup>) is a reliable and highly validated system of self-reported health outcome measures [<xref rid="pone.0277009.ref028" ref-type="bibr">28</xref>]. In this analysis, PROMIS<sup>®</sup> measures of depression and anxiety were administered using Computer Adaptive Testing (CAT) format. CAT uses validated algorithms to adapt a test based on the participant’s preceding responses. PROMIS<sup>®</sup> measures generate a raw score from which T-scores are calculated, which are standardized scores that are normed to the general population with a mean of 50 and a SD of 10.</p>
                  <p><italic toggle="yes">Cardiometabolic biomarkers</italic>. A lipoprotein particle profile was quantified from blood serum samples using a further-optimized deconvolution algorithm, called the fourth-generation lipoprotein profile algorithm, NMR spectroscopy [<xref rid="pone.0277009.ref017" ref-type="bibr">17</xref>]. The lipid biomarkers were calculated from the amplitudes of their spectroscopically unique lipid methyl group NMR signals. Particle concentration, concentration of subclasses by size (e.g., large, medium, small), and particle size were measured for all lipoprotein classes (TRL-Ps, LDL-Ps, HDL-Ps). Glycosylated acute phase proteins (GlycA), a novel inflammatory biomarker, reflects both increased glycan complexity and circulating acute-phase protein levels during local and systematic inflammation [<xref rid="pone.0277009.ref017" ref-type="bibr">17</xref>]. Lipoprotein insulin resistance (LP-IR), a novel composite metabolomic biomarker, captures the multidimensional effects of insulin resistance (IR) on the lipoprotein metabolic chain. Six lipoprotein parameters showing the strongest association with IR and prediabetes, including large TRL-P, TRL particle size (TRL-Z), small LDL-P, large HDL-P, LDL particle size (LDL-Z), and HDL particle size (HDL-Z), were used to derive LP-IR scores. LP-IR scores range from 0 (<italic toggle="yes">Most insulin sensitive</italic>) to 100 (<italic toggle="yes">Most insulin resistant</italic>) [<xref rid="pone.0277009.ref017" ref-type="bibr">17</xref>].</p>
                </sec>
              </sec>
              <sec id="sec009">
                <title>Statistical analysis</title>
                <p>Power analysis was conducted based on the primary end point of perceived stress. We used a two-side hypothesis that the perceived stress level would differ between the intervention group and the control group. Based on a Cohen’s d effect size of 0.6 and correlation of 0.8 between two time points from our previous study [<xref rid="pone.0277009.ref029" ref-type="bibr">29</xref>], with 80% power and type I error of 0.05, to detect a time-averaged difference between the intervention group and the control group, we estimated that we need 39 participants in each group [<xref rid="pone.0277009.ref030" ref-type="bibr">30</xref>]. However, after four years of recruiting and changes to the HSCT transplant program, we experienced challenges of recruitment and closed the study to further recruitment. Descriptive statistics (mean and SD for normally distributed continuous data, median and interquartile range for ordinal and non-normal data, frequencies and percentages for categorical data) were used to describe the demographic characteristics, perceived stress, psychological outcomes, and NMR-measured cardiometabolic biomarkers at the baseline and after six weeks of the intervention. Linear mixed models with time, group, and time by group interaction were used to analyze the effects of the intervention on the outcome measures over time. All variables at the baseline were tested if they were significantly different between the intervention and control groups. All data analyses were conducted using IBM SPSS statistics software, version 26.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec010">
              <title>Results</title>
              <p>Of the 226 caregivers screened for the study, 108 were eligible and 50 agreed to participate, were enrolled, and then were randomly assigned to either the intervention group (n = 25) or the control group (n = 25) (<xref rid="pone.0277009.g001" ref-type="fig">Fig 1</xref>). Six of the 50 participants dropped out before completing the study because of lack of interest (n = 1), feelings of being overwhelmed (n = 3), and death of the patient (n = 2).</p>
              <fig position="float" id="pone.0277009.g001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0277009.g001</object-id>
                <label>Fig 1</label>
                <caption>
                  <title>Consolidate Standards of Reporting Trials (CONSORT) flow diagram.</title>
                </caption>
                <graphic xlink:href="pone.0277009.g001" position="float"/>
              </fig>
              <p>The baseline caregiver and patient characteristics of the two groups are detailed in <xref rid="pone.0277009.t001" ref-type="table">Table 1</xref>. The groups did not differ on any of the baseline characteristics. The intervention group reported practicing the yoga intervention for 34.71 days (SD = 8.12), with a range of 16 to 42 days, and 652.95 minutes (SD = 159.08), with a range of 320 to 840 minutes. Throughout the six weeks of the intervention, the average weekly completion rates of those who completed the 20-minute intervention in its entirety ranged between 63% and 75%. No adverse effects were reported by the participants during the duration of the study. Cardiometabolic biomarkers are displayed in <xref rid="pone.0277009.t002" ref-type="table">Table 2</xref>. The intervention group reported higher levels of large HDL-P than the control group at the baseline (<italic toggle="yes">p =</italic> 0.034). Otherwise, there were no significant differences between the two groups in cardiometabolic biomarkers.</p>
              <table-wrap position="float" id="pone.0277009.t001">
                <object-id pub-id-type="doi">10.1371/journal.pone.0277009.t001</object-id>
                <label>Table 1</label>
                <caption>
                  <title>General characteristics at baseline (N = 50).</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0277009.t001" id="pone.0277009.t001g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="2" colspan="1">Variables</th>
                        <th align="center" colspan="3" rowspan="1">N (%) Mean (SD), range</th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">Total (n = 50)</th>
                        <th align="center" rowspan="1" colspan="1">Intervention group (n = 25)</th>
                        <th align="center" rowspan="1" colspan="1">Control group (n = 25)</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">
                          <bold>Caregiver characteristics</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (years)</td>
                        <td align="right" rowspan="1" colspan="1">44.94 (15.21), 18–74</td>
                        <td align="right" rowspan="1" colspan="1">47.32 (15.31), 18–74</td>
                        <td align="right" rowspan="1" colspan="1">42.56 (15.04), 18–66</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Sex</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">  Female</td>
                        <td align="right" rowspan="1" colspan="1">42 (84.0)</td>
                        <td align="right" rowspan="1" colspan="1">22 (88.0)</td>
                        <td align="right" rowspan="1" colspan="1">20 (80.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Race/ethnicity</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">  White/Non-Hispanic</td>
                        <td align="right" rowspan="1" colspan="1">25 (50.0)</td>
                        <td align="right" rowspan="1" colspan="1">13 (52.0)</td>
                        <td align="right" rowspan="1" colspan="1">12 (48.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">  Non-White/Non-Hispanic</td>
                        <td align="right" rowspan="1" colspan="1">15 (30.0)</td>
                        <td align="right" rowspan="1" colspan="1">9 (36.0)</td>
                        <td align="right" rowspan="1" colspan="1">6 (24.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">  Hispanic</td>
                        <td align="right" rowspan="1" colspan="1">10 (20.0)</td>
                        <td align="right" rowspan="1" colspan="1">3 (12.0)</td>
                        <td align="right" rowspan="1" colspan="1">7 (28.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Marital status</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Married/cohabiting</td>
                        <td align="right" rowspan="1" colspan="1">39 (78.0)</td>
                        <td align="right" rowspan="1" colspan="1">21 (84.0)</td>
                        <td align="right" rowspan="1" colspan="1">18 (72.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Not married<xref rid="t001fn003" ref-type="table-fn"><sup>a</sup></xref></td>
                        <td align="right" rowspan="1" colspan="1">11 (22.0)</td>
                        <td align="right" rowspan="1" colspan="1">4 (16.0)</td>
                        <td align="right" rowspan="1" colspan="1">7 (28.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Annual household income</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> &lt; $50,000</td>
                        <td align="right" rowspan="1" colspan="1">20 (47.0)</td>
                        <td align="right" rowspan="1" colspan="1">10 (47.6)</td>
                        <td align="right" rowspan="1" colspan="1">10 (45.5)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> $50,000-$89,000</td>
                        <td align="right" rowspan="1" colspan="1">7 (16.0)</td>
                        <td align="right" rowspan="1" colspan="1">4 (19.0)</td>
                        <td align="right" rowspan="1" colspan="1">3 (13.6)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> &gt; $89,000</td>
                        <td align="right" rowspan="1" colspan="1">16 (37.0)</td>
                        <td align="right" rowspan="1" colspan="1">7 (33.4)</td>
                        <td align="right" rowspan="1" colspan="1">9 (40.9)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Employment status</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Full-time</td>
                        <td align="right" rowspan="1" colspan="1">18 (36.0)</td>
                        <td align="right" rowspan="1" colspan="1">8 (32.0)</td>
                        <td align="right" rowspan="1" colspan="1">10 (40.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Part-time</td>
                        <td align="right" rowspan="1" colspan="1">12 (24.0)</td>
                        <td align="right" rowspan="1" colspan="1">6 (24.0)</td>
                        <td align="right" rowspan="1" colspan="1">6 (24.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Not working<xref rid="t001fn004" ref-type="table-fn"><sup>b</sup></xref></td>
                        <td align="right" rowspan="1" colspan="1">20 (40.0)</td>
                        <td align="right" rowspan="1" colspan="1">11 (44.0)</td>
                        <td align="right" rowspan="1" colspan="1">9 (36.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Changes in caregiver employment</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Yes</td>
                        <td align="right" rowspan="1" colspan="1">40 (80.0)</td>
                        <td align="right" rowspan="1" colspan="1">20 (80.0)</td>
                        <td align="right" rowspan="1" colspan="1">20 (80.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> No</td>
                        <td align="right" rowspan="1" colspan="1">10 (20.0)</td>
                        <td align="right" rowspan="1" colspan="1">5 (20.0)</td>
                        <td align="right" rowspan="1" colspan="1">5 (20.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td>
                        <td align="right" rowspan="1" colspan="1">28.13 (6.15), 18.5–46.5</td>
                        <td align="right" rowspan="1" colspan="1">27.26 (5.81), 18.50–44.4</td>
                        <td align="right" rowspan="1" colspan="1">29.01 (6.46), 19.7–46.5</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Waist circumference</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Male</td>
                        <td align="right" rowspan="1" colspan="1">100.38 (8.75), 88–111</td>
                        <td align="right" rowspan="1" colspan="1">100.67 (7.29), 92.5–106.5</td>
                        <td align="right" rowspan="1" colspan="1">100.20 (10.35), 88–111</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Female</td>
                        <td align="right" rowspan="1" colspan="1">90.58 (14.30), 65–136</td>
                        <td align="right" rowspan="1" colspan="1">90.92 (15.84), 65–136</td>
                        <td align="right" rowspan="1" colspan="1">90.21 (12.79), 70–124</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">SBP (mg/dL)</td>
                        <td align="right" rowspan="1" colspan="1">113.97 (13.31), 88–144</td>
                        <td align="right" rowspan="1" colspan="1">113.53 (12.24), 94–144</td>
                        <td align="right" rowspan="1" colspan="1">114.41 (14.53), 88–143</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">DBP (mg/dL)</td>
                        <td align="right" rowspan="1" colspan="1">67.37 (9.50), 49–91</td>
                        <td align="right" rowspan="1" colspan="1">66.84 (8.88), 49–84</td>
                        <td align="right" rowspan="1" colspan="1">67.90 (10.25), 51–91</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Chronic health problems</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Yes</td>
                        <td align="right" rowspan="1" colspan="1">36 (72.0)</td>
                        <td align="right" rowspan="1" colspan="1">17 (68.0)</td>
                        <td align="right" rowspan="1" colspan="1">19 (76.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> No</td>
                        <td align="right" rowspan="1" colspan="1">14 (28.0)</td>
                        <td align="right" rowspan="1" colspan="1">8 (32.0)</td>
                        <td align="right" rowspan="1" colspan="1">6 (24.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Relationships with patient</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Spouse</td>
                        <td align="right" rowspan="1" colspan="1">25 (50.0)</td>
                        <td align="right" rowspan="1" colspan="1">12 (48.0)</td>
                        <td align="right" rowspan="1" colspan="1">13 (52.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Non-spouse</td>
                        <td align="right" rowspan="1" colspan="1">25 (50.0)</td>
                        <td align="right" rowspan="1" colspan="1">13 (52.0)</td>
                        <td align="right" rowspan="1" colspan="1">12 (48.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Caregiving days/week</td>
                        <td align="right" rowspan="1" colspan="1">6.76 (1.03), 2–7</td>
                        <td align="right" rowspan="1" colspan="1">7.00 (0.00), 0–7</td>
                        <td align="right" rowspan="1" colspan="1">6.52 (1.42), 2–7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Caregiving hours/day</td>
                        <td align="right" rowspan="1" colspan="1">14.30 (7.89), 1.50–24.0</td>
                        <td align="right" rowspan="1" colspan="1">14.44 (8.13), 1.5–24</td>
                        <td align="right" rowspan="1" colspan="1">14.16 (7.82), 2–24</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Perceived stress<xref rid="t001fn005" ref-type="table-fn"><sup>c</sup></xref></td>
                        <td align="right" rowspan="1" colspan="1">54.83 (10.62), 30.77–76.13</td>
                        <td align="right" rowspan="1" colspan="1">53.49 (11.44), 34.78–76.13</td>
                        <td align="right" rowspan="1" colspan="1">56.17 (9.78), 30.78–74.78</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Depression<xref rid="t001fn006" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td align="right" rowspan="1" colspan="1">51.04 (7.78), 34.17–71.37</td>
                        <td align="right" rowspan="1" colspan="1">49.23 (7.76), 34.17–71.37       </td>
                        <td align="right" rowspan="1" colspan="1">52.85 (7.51), 41.73–69.10</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Anxiety<xref rid="t001fn006" ref-type="table-fn"><sup>d</sup></xref></td>
                        <td align="right" rowspan="1" colspan="1">60.46 (7.01), 44.55–75.54</td>
                        <td align="right" rowspan="1" colspan="1">60.70 (6.94), 44.55–73.44</td>
                        <td align="right" rowspan="1" colspan="1">60.22 (7.21), 46.69–75.54</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">
                          <bold>Patient characteristics</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Age (years)</td>
                        <td align="right" rowspan="1" colspan="1">36.68 (14.03), 18–66</td>
                        <td align="right" rowspan="1" colspan="1">36.20 (13.48), 18–66</td>
                        <td align="right" rowspan="1" colspan="1">37.16 (14.83), 20–65</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Patient sex</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Male</td>
                        <td align="right" rowspan="1" colspan="1">33 (66.0)</td>
                        <td align="right" rowspan="1" colspan="1">16 (64.0)</td>
                        <td align="right" rowspan="1" colspan="1">17 (68.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Primary disease<xref rid="t001fn007" ref-type="table-fn"><sup>e</sup></xref></td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Hematological malignancy</td>
                        <td align="right" rowspan="1" colspan="1">26 (52.0)</td>
                        <td align="right" rowspan="1" colspan="1">10 (40.0)</td>
                        <td align="right" rowspan="1" colspan="1">16 (64.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Non-hematological malignancy</td>
                        <td align="right" rowspan="1" colspan="1">24 (48.0)</td>
                        <td align="right" rowspan="1" colspan="1">15 (60.0)</td>
                        <td align="right" rowspan="1" colspan="1">9 (36.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Type of transplant</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> RIC</td>
                        <td align="right" rowspan="1" colspan="1">32 (64.0)</td>
                        <td align="right" rowspan="1" colspan="1">18 (72.0)</td>
                        <td align="right" rowspan="1" colspan="1">14 (56.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Myeloablative</td>
                        <td align="right" rowspan="1" colspan="1">18 (36.0)</td>
                        <td align="right" rowspan="1" colspan="1">7 (28.0)</td>
                        <td align="right" rowspan="1" colspan="1">11 (44.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Stem cell source</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Peripheral blood</td>
                        <td align="right" rowspan="1" colspan="1">39 (78.0)</td>
                        <td align="right" rowspan="1" colspan="1">19 (76.0)</td>
                        <td align="right" rowspan="1" colspan="1">20 (80.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Bone marrow</td>
                        <td align="right" rowspan="1" colspan="1">10 (20.0)</td>
                        <td align="right" rowspan="1" colspan="1">5 (20.0)</td>
                        <td align="right" rowspan="1" colspan="1">5 (20.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Cord</td>
                        <td align="right" rowspan="1" colspan="1">1 (2.0)</td>
                        <td align="right" rowspan="1" colspan="1">1 (4.0)</td>
                        <td align="right" rowspan="1" colspan="1">0 (0.0)</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="4" rowspan="1">Disease risk category</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Low</td>
                        <td align="right" rowspan="1" colspan="1">39 (78.0)</td>
                        <td align="right" rowspan="1" colspan="1">22 (88.0)</td>
                        <td align="right" rowspan="1" colspan="1">17 (68.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Intermediate</td>
                        <td align="right" rowspan="1" colspan="1">5 (10.0)</td>
                        <td align="right" rowspan="1" colspan="1">1 (4.0)</td>
                        <td align="right" rowspan="1" colspan="1">4 (16.0)</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> High</td>
                        <td align="right" rowspan="1" colspan="1">6 (12.0)</td>
                        <td align="right" rowspan="1" colspan="1">2 (8.0)</td>
                        <td align="right" rowspan="1" colspan="1">4 (16.0)</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t001fn001">
                    <p>Note. Numbers may not sum to total due to missing data.</p>
                  </fn>
                  <fn id="t001fn002">
                    <p>BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure; RIC, reduced intensity conditioning.</p>
                  </fn>
                  <fn id="t001fn003">
                    <p><sup>a</sup>Not married = never married, divorced, separated, widowed,</p>
                  </fn>
                  <fn id="t001fn004">
                    <p><sup>b</sup>Not working = student, retired, disability, unemployed,</p>
                  </fn>
                  <fn id="t001fn005">
                    <p><sup>c</sup>Assessed using NIH toolbox,</p>
                  </fn>
                  <fn id="t001fn006">
                    <p><sup>d</sup>Assessed using Patient-Reported Outcome Measurement Information System<sup>®</sup> (PROMIS<sup>®</sup>),</p>
                  </fn>
                  <fn id="t001fn007">
                    <p><sup>e</sup>Primary disease, hematological malignancy = chronic myelogenous leukemia, acute lymphocytic leukemia, acute myelogenous leukemia, and chronic lymphocytic leukemia, Hodgkin’s and non-Hodgkin’s lymphoma; non-hematological malignancy = aplastic anemia, sickle cell disease, inherited bone marrow failure disorders, primary immunodeficiency disease.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <table-wrap position="float" id="pone.0277009.t002">
                <object-id pub-id-type="doi">10.1371/journal.pone.0277009.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>Levels of cardiometabolic biomarkers in intervention and control groups at baseline.</title>
                </caption>
                <alternatives>
                  <graphic xlink:href="pone.0277009.t002" id="pone.0277009.t002g" position="float"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="left" rowspan="2" colspan="1">Variables</th>
                        <th align="center" colspan="2" rowspan="1">Intervention group (n = 25)</th>
                        <th align="center" colspan="2" rowspan="1">Control group (n = 25)</th>
                        <th align="center" colspan="2" rowspan="1">Refence range value<xref rid="t002fn002" ref-type="table-fn"><sup>a</sup></xref></th>
                      </tr>
                      <tr>
                        <th align="center" rowspan="1" colspan="1">Mean (SD)</th>
                        <th align="center" rowspan="1" colspan="1">Range</th>
                        <th align="center" rowspan="1" colspan="1">Mean (SD)</th>
                        <th align="center" rowspan="1" colspan="1">Range</th>
                        <th align="center" rowspan="1" colspan="1">Mean (SD)</th>
                        <th align="center" rowspan="1" colspan="1">Range</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>Triglyceride-rich Particles (nmol/L)</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Total TRL-P</td>
                        <td align="center" rowspan="1" colspan="1">115.61 (96.99)</td>
                        <td align="center" rowspan="1" colspan="1">15.7–484.5</td>
                        <td align="center" rowspan="1" colspan="1">112.85 (70.91)</td>
                        <td align="center" rowspan="1" colspan="1">27.4–273.5</td>
                        <td align="center" rowspan="1" colspan="1">125.2 (61.6)</td>
                        <td align="center" rowspan="1" colspan="1">42–239</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Very Large TRL-P</td>
                        <td align="center" rowspan="1" colspan="1">0.14 (.09)</td>
                        <td align="center" rowspan="1" colspan="1">0–0.3</td>
                        <td align="center" rowspan="1" colspan="1">0.27 (0.49)</td>
                        <td align="center" rowspan="1" colspan="1">0–2.5</td>
                        <td align="center" rowspan="1" colspan="1">0.4 (1.0)</td>
                        <td align="center" rowspan="1" colspan="1">0–1.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Large TRL-P</td>
                        <td align="center" rowspan="1" colspan="1">1.20 (2.35)</td>
                        <td align="center" rowspan="1" colspan="1">0–11.4</td>
                        <td align="center" rowspan="1" colspan="1">1.6 (2.79)</td>
                        <td align="center" rowspan="1" colspan="1">0–13.9</td>
                        <td align="center" rowspan="1" colspan="1">2.9 (6.5)</td>
                        <td align="center" rowspan="1" colspan="1">0–12.8</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Medium TRL-P</td>
                        <td align="center" rowspan="1" colspan="1">17.96 (16.41)</td>
                        <td align="center" rowspan="1" colspan="1">0–57.6</td>
                        <td align="center" rowspan="1" colspan="1">18.28 (12.67)</td>
                        <td align="center" rowspan="1" colspan="1">0–40.6</td>
                        <td align="center" rowspan="1" colspan="1">17.9 (16.2)</td>
                        <td align="center" rowspan="1" colspan="1">0.3–48.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Small TRL-P</td>
                        <td align="center" rowspan="1" colspan="1">45.68 (36.79)</td>
                        <td align="center" rowspan="1" colspan="1">0–147</td>
                        <td align="center" rowspan="1" colspan="1">29.62 (23.02)</td>
                        <td align="center" rowspan="1" colspan="1">4.6–99.7</td>
                        <td align="center" rowspan="1" colspan="1">56.6 (37.5)</td>
                        <td align="center" rowspan="1" colspan="1">7.3–124.4</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Very Small TRL-P</td>
                        <td align="center" rowspan="1" colspan="1">50.63 (67.34)</td>
                        <td align="center" rowspan="1" colspan="1">0–281.20</td>
                        <td align="center" rowspan="1" colspan="1">63.08 (69.58)</td>
                        <td align="center" rowspan="1" colspan="1">0–230.8</td>
                        <td align="center" rowspan="1" colspan="1">47.5 (46.9)</td>
                        <td align="center" rowspan="1" colspan="1">0–142.3</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>LDL Particles (nmol/L)</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Total LDL-P</td>
                        <td align="center" rowspan="1" colspan="1">1557.6 (447.81)</td>
                        <td align="center" rowspan="1" colspan="1">1001–2626</td>
                        <td align="center" rowspan="1" colspan="1">14300 (369.39)</td>
                        <td align="center" rowspan="1" colspan="1">831–2398</td>
                        <td align="left" rowspan="1" colspan="1">1454.0 (393.0)</td>
                        <td align="center" rowspan="1" colspan="1">891–2150</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Large LDL-P</td>
                        <td align="center" rowspan="1" colspan="1">239.72 (180.44)</td>
                        <td align="center" rowspan="1" colspan="1">0–631</td>
                        <td align="center" rowspan="1" colspan="1">158.12 (180.80)</td>
                        <td align="center" rowspan="1" colspan="1">0–727</td>
                        <td align="left" rowspan="1" colspan="1">309.0 (223.0)</td>
                        <td align="center" rowspan="1" colspan="1">17–748</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Medium LDL-P</td>
                        <td align="center" rowspan="1" colspan="1">702.88 (381.85)</td>
                        <td align="center" rowspan="1" colspan="1">0–1528</td>
                        <td align="center" rowspan="1" colspan="1">597.96 (386.38)</td>
                        <td align="center" rowspan="1" colspan="1">0–1182</td>
                        <td align="center" rowspan="1" colspan="1">676.0 (405.0)</td>
                        <td align="center" rowspan="1" colspan="1">0–1377</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Small LDL-P</td>
                        <td align="center" rowspan="1" colspan="1">615.12 (493.96)</td>
                        <td align="center" rowspan="1" colspan="1">71–2017</td>
                        <td align="center" rowspan="1" colspan="1">674 (594.13)</td>
                        <td align="center" rowspan="1" colspan="1">0–2134</td>
                        <td align="center" rowspan="1" colspan="1">469.0 (431.0)</td>
                        <td align="center" rowspan="1" colspan="1">13–1318</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>HDL Particles (μmol/L)</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Total HDL-P</td>
                        <td align="center" rowspan="1" colspan="1">19.7 (3.14)</td>
                        <td align="center" rowspan="1" colspan="1">14.1–24.7</td>
                        <td align="center" rowspan="1" colspan="1">19.39 (2.97)</td>
                        <td align="center" rowspan="1" colspan="1">14.6–24.8</td>
                        <td align="center" rowspan="1" colspan="1">24.0 (3.0)</td>
                        <td align="center" rowspan="1" colspan="1">19.2–29.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Large HDL-P<xref rid="t002fn003" ref-type="table-fn">*</xref></td>
                        <td align="center" rowspan="1" colspan="1">3.08 (1.99)</td>
                        <td align="center" rowspan="1" colspan="1">0.5–7.3</td>
                        <td align="center" rowspan="1" colspan="1">2.04 (1.44)</td>
                        <td align="center" rowspan="1" colspan="1">2.0–4.7</td>
                        <td align="center" rowspan="1" colspan="1">2.5 (1.9)</td>
                        <td align="center" rowspan="1" colspan="1">0.2–6.3</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Medium HDL-P</td>
                        <td align="center" rowspan="1" colspan="1">3.97 (2.13)</td>
                        <td align="center" rowspan="1" colspan="1">1.2–9.2</td>
                        <td align="center" rowspan="1" colspan="1">3.54 (1.54)</td>
                        <td align="center" rowspan="1" colspan="1">1.0–6.6</td>
                        <td align="center" rowspan="1" colspan="1">7.7 (2.7)</td>
                        <td align="center" rowspan="1" colspan="1">3.7–12.6</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Small HDL-P</td>
                        <td align="center" rowspan="1" colspan="1">12.65 (4.47)</td>
                        <td align="center" rowspan="1" colspan="1">2.4–19.8</td>
                        <td align="center" rowspan="1" colspan="1">13.80 (2.83)</td>
                        <td align="center" rowspan="1" colspan="1">7.7–19.8</td>
                        <td align="center" rowspan="1" colspan="1">13.8 (3.4)</td>
                        <td align="center" rowspan="1" colspan="1">8.1–19.6</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>Mean Particles Sizes (nm)</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> TRL-Z</td>
                        <td align="center" rowspan="1" colspan="1">41.22 (6.19)</td>
                        <td align="center" rowspan="1" colspan="1">33.3–63.7</td>
                        <td align="center" rowspan="1" colspan="1">43.84 (7.00)</td>
                        <td align="center" rowspan="1" colspan="1">30.8–67.4</td>
                        <td align="center" rowspan="1" colspan="1">44.0 (8.4)</td>
                        <td align="center" rowspan="1" colspan="1">33.8–60.9</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> LDL-Z</td>
                        <td align="center" rowspan="1" colspan="1">20.91 (0.49)</td>
                        <td align="center" rowspan="1" colspan="1">19.8–21.6</td>
                        <td align="center" rowspan="1" colspan="1">20.76 (0.56)</td>
                        <td align="center" rowspan="1" colspan="1">19.7–21.7</td>
                        <td align="center" rowspan="1" colspan="1">21.0 (0.5)</td>
                        <td align="center" rowspan="1" colspan="1">20.1–21.7</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> HDL-Z</td>
                        <td align="center" rowspan="1" colspan="1">9.15 (0.44)</td>
                        <td align="center" rowspan="1" colspan="1">8.4–10</td>
                        <td align="center" rowspan="1" colspan="1">8.95 (0.36)</td>
                        <td align="center" rowspan="1" colspan="1">8.3–9.6</td>
                        <td align="center" rowspan="1" colspan="1">9.0 (0.4)</td>
                        <td align="center" rowspan="1" colspan="1">8.3–9.8</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>Lipids and Apolipoproteins (mg/dL)</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Total cholesterol</td>
                        <td align="center" rowspan="1" colspan="1">183.36 (37.04)</td>
                        <td align="center" rowspan="1" colspan="1">129–272</td>
                        <td align="center" rowspan="1" colspan="1">165.32 (29.80)</td>
                        <td align="center" rowspan="1" colspan="1">114–223</td>
                        <td align="center" rowspan="1" colspan="1">193.8 (36.5)</td>
                        <td align="center" rowspan="1" colspan="1">140–256</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> LDL-C</td>
                        <td align="center" rowspan="1" colspan="1">104.52 (29.28)</td>
                        <td align="center" rowspan="1" colspan="1">67–182</td>
                        <td align="center" rowspan="1" colspan="1">93.40 (23.18)</td>
                        <td align="center" rowspan="1" colspan="1">57–135</td>
                        <td align="center" rowspan="1" colspan="1">110.5 (30.7)</td>
                        <td align="center" rowspan="1" colspan="1">63–163</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> HDL-C</td>
                        <td align="center" rowspan="1" colspan="1">56.08 (13.69)</td>
                        <td align="center" rowspan="1" colspan="1">31–85</td>
                        <td align="center" rowspan="1" colspan="1">49.92 (12.35)</td>
                        <td align="center" rowspan="1" colspan="1">34–72</td>
                        <td align="center" rowspan="1" colspan="1">61.1 (14.4)</td>
                        <td align="center" rowspan="1" colspan="1">41–88</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Triglycerides</td>
                        <td align="center" rowspan="1" colspan="1">109.00 (50.97)</td>
                        <td align="center" rowspan="1" colspan="1">51–244</td>
                        <td align="center" rowspan="1" colspan="1">107.88 (43.52)</td>
                        <td align="center" rowspan="1" colspan="1">51–237</td>
                        <td align="center" rowspan="1" colspan="1">119.3 (89.8)</td>
                        <td align="center" rowspan="1" colspan="1">43–276</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Apolipoprotein A1</td>
                        <td align="center" rowspan="1" colspan="1">133.32 (21.71)</td>
                        <td align="center" rowspan="1" colspan="1">90–169</td>
                        <td align="center" rowspan="1" colspan="1">123.92 (21.91)</td>
                        <td align="center" rowspan="1" colspan="1">85–166</td>
                        <td align="center" rowspan="1" colspan="1">156.8 (27.8)</td>
                        <td align="center" rowspan="1" colspan="1">116–209</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> Apolipoprotein B</td>
                        <td align="center" rowspan="1" colspan="1">90.04 (27.18)</td>
                        <td align="center" rowspan="1" colspan="1">56–167</td>
                        <td align="center" rowspan="1" colspan="1">81.68 (20.93)</td>
                        <td align="center" rowspan="1" colspan="1">47–130</td>
                        <td align="center" rowspan="1" colspan="1">87.1 (23.6)</td>
                        <td align="center" rowspan="1" colspan="1">53–127</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>Inflammatory Biomarker (μmol/L)</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> GlycA</td>
                        <td align="center" rowspan="1" colspan="1">374.92 (51.14)</td>
                        <td align="center" rowspan="1" colspan="1">283–510</td>
                        <td align="center" rowspan="1" colspan="1">367.16 (59.14)</td>
                        <td align="center" rowspan="1" colspan="1">258–478</td>
                        <td align="center" rowspan="1" colspan="1">402.4 (65.8)</td>
                        <td align="center" rowspan="1" colspan="1">307–524</td>
                      </tr>
                      <tr>
                        <td align="left" colspan="7" rowspan="1">
                          <bold>Composite Metabolomic Marker</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1"> LP-IR</td>
                        <td align="center" rowspan="1" colspan="1">27.76 (23.35)</td>
                        <td align="center" rowspan="1" colspan="1">1–94</td>
                        <td align="center" rowspan="1" colspan="1">38.28 (22.27)</td>
                        <td align="center" rowspan="1" colspan="1">3–92</td>
                        <td align="center" rowspan="1" colspan="1">36.0 (24.5)</td>
                        <td align="center" rowspan="1" colspan="1">3–83</td>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t002fn001">
                    <p>Note. GlycA, glycoprotein acetylation; HDL-C, high-density lipoprotein cholesterol; HDL-P, high-density lipoprotein particles; HDL-Z, high-density lipoprotein size; LDL-C, low-density lipoprotein cholesterol, LDL-P, low-density lipoprotein particles; LDL-Z, low-density lipoprotein size; LP-IR, lipoprotein insulin resistance index; TRL-P, triglyceride rich lipoprotein particles; TRL-Z, triglyceride rich lipoprotein size.</p>
                  </fn>
                  <fn id="t002fn002">
                    <p><sup>a</sup>Reference range values are from a representative sampling (n = 698) of the general population, comprised of apparently healthy men (n = 284) and women (n = 414) aged 18 to 84 years (mean 39 years).</p>
                  </fn>
                  <fn id="t002fn003">
                    <p>*<italic toggle="yes">p</italic> &lt; .05</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="sec011">
                <title>Perceived stress</title>
                <p>Six percent of our sample reported low levels of perceived stress and 32% reported high levels of perceived stress. There were no significant differences found for group or time, or the interaction between group and time for perceived stress. A post-hoc power analysis for the primary outcome was performed. The actual effect size for time averaged perceived stress between groups was approximately 0.4; the correlation between time points was approximately 0.8. Thus, with the sample size of 50, the actual power for the primary outcome was 32%, not the desired 80%.</p>
              </sec>
              <sec id="sec012">
                <title>Depression and anxiety</title>
                <p>There were no significant differences found for group or time, or the interaction between group and time for depression and anxiety.</p>
              </sec>
              <sec id="sec013">
                <title>Cardiometabolic biomarkers</title>
                <p>There were significant effects in two of cardiometabolic biomarkers, large TRL-P and LP-IR (<xref rid="pone.0277009.t003" ref-type="table">Table 3</xref>). There was a significant interaction effect between group and time in large TRL-P (<italic toggle="yes">F</italic> (1,43) = 10.16, <italic toggle="yes">p</italic> = 0.003). The levels of large TRL-P significantly increased over time in the control group (mean difference [MD] = 1.68; confidence interval [CI] = [0.86, 2.51], <italic toggle="yes">p &lt;</italic> .001) but did not significantly change in the intervention group (MD = -0.15; CI = [-0.96, 0.66], <italic toggle="yes">p</italic> = 0.718) (<xref rid="pone.0277009.g002" ref-type="fig">Fig 2a</xref>). A significant interaction effect between group and time was found in LP-IR (<italic toggle="yes">F</italic> (1,42) = 4.28, <italic toggle="yes">p</italic> = 0.045), with the trajectory of LP-IR increasing overtime in the control group (MD = 5.67; CI = [1.15, 10.18], <italic toggle="yes">p =</italic> 0.015) while a nonsignificant change in LP-IR for the intervention group (MD = -0.81; CI = [-5.22, 3.61], <italic toggle="yes">p</italic> = 0.714) (<xref rid="pone.0277009.g002" ref-type="fig">Fig 2b</xref>).</p>
                <fig position="float" id="pone.0277009.g002">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277009.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Mean cardiometabolic biomarkers levels over time for the intervention and control groups.</title>
                    <p>a. Predicted large TRL-p overtime. Post-hoc analyses showed significant differences between baseline and 6 weeks for control group only (<italic toggle="yes">p</italic> &lt; 0.001). b. Predicted LP-IR over time. Post-hoc analyses showed significant differences between baseline and 6 weeks for control group only (<italic toggle="yes">p</italic> = 0.015).</p>
                  </caption>
                  <graphic xlink:href="pone.0277009.g002" position="float"/>
                </fig>
                <table-wrap position="float" id="pone.0277009.t003">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0277009.t003</object-id>
                  <label>Table 3</label>
                  <caption>
                    <title>Cardiometabolic biomarker outcomes that differed by group over time.</title>
                  </caption>
                  <alternatives>
                    <graphic xlink:href="pone.0277009.t003" id="pone.0277009.t003g" position="float"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" rowspan="2" colspan="1">Outcome</th>
                          <th align="center" rowspan="2" colspan="1">Measurement</th>
                          <th align="center" rowspan="1" colspan="1">Intervention group</th>
                          <th align="center" rowspan="1" colspan="1">Control group</th>
                          <th align="center" colspan="2" rowspan="1">Mixed model analysis</th>
                        </tr>
                        <tr>
                          <th align="center" rowspan="1" colspan="1">Mean (SE)</th>
                          <th align="center" rowspan="1" colspan="1">Mean (SE)</th>
                          <th align="center" rowspan="1" colspan="1">Effect</th>
                          <th align="center" rowspan="1" colspan="1"><italic toggle="yes">p</italic> value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="3" colspan="1">Large TRL-P</td>
                          <td align="center" rowspan="1" colspan="1">Baseline</td>
                          <td align="center" rowspan="1" colspan="1">1.20 (0.63)</td>
                          <td align="center" rowspan="1" colspan="1">1.60 (0.63)</td>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Time</bold>
                          </td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.010</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="2" colspan="1">6 weeks</td>
                          <td align="center" rowspan="2" colspan="1">1.05 (0.64)</td>
                          <td align="center" rowspan="2" colspan="1">3.29 (0.65)</td>
                          <td align="center" rowspan="1" colspan="1">Group</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.129</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Group x time</bold>
                          </td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.003</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="3" colspan="1">LP-IR</td>
                          <td align="center" rowspan="1" colspan="1">Baseline</td>
                          <td align="center" rowspan="1" colspan="1">27.76 (4.46)</td>
                          <td align="center" rowspan="1" colspan="1">38.28 (4.46)</td>
                          <td align="center" rowspan="1" colspan="1">Time</td>
                          <td align="char" char="." rowspan="1" colspan="1">0.128</td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="2" colspan="1">6 weeks</td>
                          <td align="center" rowspan="2" colspan="1">26.95 (4.52)</td>
                          <td align="center" rowspan="2" colspan="1">43.95 (4.55)</td>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Group</bold>
                          </td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.030</bold>
                          </td>
                        </tr>
                        <tr>
                          <td align="center" rowspan="1" colspan="1">
                            <bold>Group x time</bold>
                          </td>
                          <td align="char" char="." rowspan="1" colspan="1">
                            <bold>0.045</bold>
                          </td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                  <table-wrap-foot>
                    <fn id="t003fn001">
                      <p>Note. Boldface indicates statistical significance (<italic toggle="yes">p</italic> &lt; 0.05). HDL-P, high-density lipoprotein particles; TRL-P, triglyceride rich lipoprotein particles; LP-IR, lipoprotein insulin resistance index.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec014">
              <title>Discussion</title>
              <p>Our study is the first to examine the efficacy of a six-week yoga-based stress reduction intervention to improve perceived stress, psychological outcomes, and cardiometabolic health, as measured by novel NMR lipoprotein particle concentration and size, in HSCT caregivers. Multiple studies using yoga-based meditation and mindfulness interventions have shown beneficial effects on stress and psychological symptoms [<xref rid="pone.0277009.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0277009.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0277009.ref031" ref-type="bibr">31</xref>–<xref rid="pone.0277009.ref033" ref-type="bibr">33</xref>]. However, no other study reported cardiometabolic outcomes in caregivers. In this study, there were no significant differences between the two groups in perceived stress, depression, and anxiety, nor were there within group changes in either of the two groups in these outcomes from the baseline to the trial’s end. Nevertheless, we found that the six-week yoga-based stress reduction intervention led to beneficial changes in the lipoprotein subclass profile, large TRL-P and LP-IR.</p>
              <p>In our study, it is somewhat surprising that perceived stress and symptoms of depression and anxiety did not improve in the intervention group. Perceived stress is commonly examined in yoga intervention research and is believed to be positively influenced by engagement in yoga-based stress reduction [<xref rid="pone.0277009.ref032" ref-type="bibr">32</xref>, <xref rid="pone.0277009.ref033" ref-type="bibr">33</xref>]. However, there are some conflicting reports regarding yoga-based intervention’s impact on psychological outcomes. Some studies showed beneficial results in psychological outcomes, such as depression and anxiety [<xref rid="pone.0277009.ref012" ref-type="bibr">12</xref>–<xref rid="pone.0277009.ref014" ref-type="bibr">14</xref>, <xref rid="pone.0277009.ref031" ref-type="bibr">31</xref>–<xref rid="pone.0277009.ref033" ref-type="bibr">33</xref>], while other studies did not observe significant changes in these outcomes [<xref rid="pone.0277009.ref034" ref-type="bibr">34</xref>, <xref rid="pone.0277009.ref035" ref-type="bibr">35</xref>]. One possible reason for the difference in findings between previous research and this study may be attributed to the relatively short-term intervention. Two systematic reviews assessing the effects of yoga-based stress reduction intervention in nonclinical populations, with the duration varying from four to 24 weeks, suggested that the intervention duration is an important factor of yoga effectiveness [<xref rid="pone.0277009.ref036" ref-type="bibr">36</xref>, <xref rid="pone.0277009.ref037" ref-type="bibr">37</xref>]. The optimal duration of yoga-based stress reduction intervention is unclear, but studies with longer intervention periods appear to have better results [<xref rid="pone.0277009.ref037" ref-type="bibr">37</xref>]. Thus, further studies need to collect outcomes at multiple time points to ascertain the effects of longer-term intervention on psychological outcomes in caregivers. In addition, with 50 participants, this study was not sufficiently powered to detect differences in the patient reported outcome measures between groups. Future studies should be appropriately powered to assess the effects of perceived stress by recruiting more participants, enrolling participants at higher risk, and prolonging follow-up.</p>
              <p>The most notable finding of this study was that the yoga-based stress reduction intervention appeared to be protective of negative changes in large TRL-P, which is specifically associated with IR. IR is a key risk factor of metabolic dysfunction in prediabetes and T2D, characterized by deterioration in tissue sensitivity to insulin and a compensatory increase in insulin secretion [<xref rid="pone.0277009.ref038" ref-type="bibr">38</xref>]. Impaired insulin sensitivity may contribute to occlusive vascular disease, which has been positively related to increased risk of coronary artery disease and ischemic stroke in the general population [<xref rid="pone.0277009.ref039" ref-type="bibr">39</xref>, <xref rid="pone.0277009.ref040" ref-type="bibr">40</xref>]. It is well appreciated that worsening IR was associated with lipoprotein abnormalities featured by remarkably increased large VLDL-P, without consistent changes in medium or small VLDL-P [<xref rid="pone.0277009.ref041" ref-type="bibr">41</xref>, <xref rid="pone.0277009.ref042" ref-type="bibr">42</xref>]. Large VLDL-P may be more critical in predicting atherogenic risk than medium or small VLDL-P since a greater proportion of large lighter VLDL is efficiently catabolized to small dense LDL particles, leading to an increase in serum triglycerides and cholesterol ester in the vascular intima [<xref rid="pone.0277009.ref038" ref-type="bibr">38</xref>, <xref rid="pone.0277009.ref043" ref-type="bibr">43</xref>]. Using a novel NMR platform-derived algorithm that captures five different TRL subclasses, we found that HSCT caregivers in the control group showed a significant increase in circulating large TRL-P while levels in the intervention group remained unchanged. The findings suggested a potential mechanism by which caregiving stress may increase the risk of cardiometabolic disease. These findings are strengthened by our own past research finding that “double duty caregivers” who experienced the added stress of providing care to another individual in addition to the cancer patient were more likely to have higher levels of large TRL-P than were caregivers who only provided care to the cancer patient [<xref rid="pone.0277009.ref010" ref-type="bibr">10</xref>]. We also previously found that HSCT caregivers’ levels of large VLDL-P worsened over time, while the levels remained unchanged in non-caregivers, indicating very early signs of cardiometabolic disease in these caregivers [<xref rid="pone.0277009.ref021" ref-type="bibr">21</xref>]. Perhaps caregiving stress has a bigger impact on triglyceride-rich remnant lipoprotein, and it is through this pathway that caregivers are at increased cardiometabolic risk. One of the main determinants of circulating triglycerides is the level of lipoprotein lipase, which is well known to be affected by stress [<xref rid="pone.0277009.ref044" ref-type="bibr">44</xref>].</p>
              <p>Another important finding in this study is that the yoga-based stress reduction intervention elicited notable beneficial changes in LP-IR, a novel composite metabolomic marker of IR and T2D risk. A growing body of clinical trials demonstrated that LP-IR scores were strongly associated with incidence T2D even independent of established risk factors including glucose or HBA1c levels [<xref rid="pone.0277009.ref045" ref-type="bibr">45</xref>–<xref rid="pone.0277009.ref047" ref-type="bibr">47</xref>]. Furthermore, LP-IR scores have been shown to predict future T2D in individuals at low risk for T2D based on their clinical profiles [<xref rid="pone.0277009.ref045" ref-type="bibr">45</xref>]. LP-IR scores offer a simple, reliable way to monitor a patient’s risk of T2D and the effectiveness of treatments that may prevent or delay the onset of T2D [<xref rid="pone.0277009.ref045" ref-type="bibr">45</xref>–<xref rid="pone.0277009.ref047" ref-type="bibr">47</xref>]. Previous studies evaluating the efficacy of modification interventions that incorporate diet, exercise, stress management or group support on cardiometabolic health have demonstrated the comparability of LP-IR with traditional markers for determining a patient’s IR state [<xref rid="pone.0277009.ref048" ref-type="bibr">48</xref>, <xref rid="pone.0277009.ref049" ref-type="bibr">49</xref>]. However, no other study to date has assessed the effects of a yoga-based stress reduction intervention on LP-IR. In this study, a significant improvement in LP-IR was observed in caregivers in the intervention group compared to those in the education control group. As LP-IR was sensitive to change following the yoga-based stress reduction intervention, our findings provide evidence for the clinical utility of this novel composite metabolomic marker to assess alteration in diseases risk in caregivers. In addition, our findings demonstrated that the yoga-based stress reduction intervention was effective for improving IR defined by LP-IR scores, suggesting that yoga-based stress reduction may decrease the risk of cardiometabolic disease in caregivers by preventing or delaying the onset of T2D. The exact mechanisms underlying the effects of yoga-based stress reduction on diabetes risk profiles are not yet well understood, and further studies are warranted. This study has several limitations. First, with the small sample size, the study was underpowered to detect differences in the primary outcome between groups. These factors were accompanied by the relatively short data collection period, which needs to be considered when interpreting these findings. Further studies using larger samples are needed. Second, this study recruited only caregivers of individuals receiving HSCT at the NIH Clinical Center, a unique research hospital that provides care only to individuals enrolled in research protocols. Thus, the findings may not be generalizable to caregivers of patients receiving traditional care in general hospitals or clinics. In addition, while the study revealed a relatively high and consistent overall adherence to the intervention, monitoring the correct completion of the yoga poses is not possible when participants’ completion is self-paced outside of a controlled setting. Given the growing number of people using live streaming platforms, incorporating this technology (via the real-time display of video and synchronous communications) may provide monitoring of the intervention and permit instant feedback from participants during the practice improving intervention fidelity. Finally, since this study was designed to measure study outcomes only at the baseline and six weeks after the completion of the intervention, we did not measure study outcomes immediately before and after the 20-minute intervention. This would have allowed us to examine whether the intervention might have relieved levels of stress or psychological outcomes temporarily following the completion of the audio file intervention. This temporary respite may have been enough to protect the intervention participants from negative changes in cardiometabolic biomarkers. Assessment of measures across multiple time points (e.g., pre and post a single yoga session in addition to pre and post the entire study) and longer follow-up could further inform how stress or psychological outcomes change throughout the caregiving trajectory and which mechanisms may lead to changes in cardiometabolic health in HSCT caregivers.</p>
            </sec>
            <sec sec-type="conclusions" id="sec015">
              <title>Conclusions</title>
              <p>In this study, yoga-based stress reduction was effective for protecting cardiometabolic health in HSCT caregivers, possibly preventing or delaying progression toward T2D. We reported that detailed lipoprotein profiling might provide insight into the mechanisms underlying the protective influence of gentle yoga poses and breathing exercises in preventing negative changes in vascular atherogenicity and insulin sensitivity. Although additional research is needed to determine factors influencing long-term changes in IR, health care providers should consider the benefits of yoga-based stress reduction for improving insulin sensitivity and coronary artery disease risk when developing tailored strategies to maintain optimal cardiometabolic health of family caregivers.</p>
            </sec>
            <sec id="sec016" sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material id="pone.0277009.s001" position="float" content-type="local-data">
                <label>S1 Checklist</label>
                <caption>
                  <title>CONSORT checklist.</title>
                  <p>(DOC)</p>
                </caption>
                <media xlink:href="pone.0277009.s001.doc">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material id="pone.0277009.s002" position="float" content-type="local-data">
                <label>S1 File</label>
                <caption>
                  <title>Study protocol.</title>
                  <p>(DOCX)</p>
                </caption>
                <media xlink:href="pone.0277009.s002.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>The authors thank and to the caregivers who participated in this research study. The authors are grateful for the contributions made to the yoga-based stress reduction intervention used in this study by Advanced Iyengar Yoga Instructor John Schumacher.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pone.0277009.ref001">
                <label>1</label>
                <mixed-citation publication-type="other">National Alliance for Caregiving. Caregiving in the U.S. 2020. <ext-link xlink:href="https://www.aarp.org/content/dam/aarp/ppi/2020/05/full-report-caregiving-in-the-united-states" ext-link-type="uri">https://www.aarp.org/content/dam/aarp/ppi/2020/05/full-report-caregiving-in-the-united-states</ext-link>.</mixed-citation>
              </ref>
              <ref id="pone.0277009.ref002">
                <label>2</label>
                <mixed-citation publication-type="other">National Alliance for Caregiving. Cancer Caregiving in the U.S.: An intense, episodic, and challenging care experience. <ext-link xlink:href="https://www.caregiving.org/wp-content/uploads/2020/05/CancerCaregivingReport_FINAL_June-17-2016.pdf" ext-link-type="uri">https://www.caregiving.org/wp-content/uploads/2020/05/CancerCaregivingReport_FINAL_June-17-2016.pdf</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Arnaout</surname><given-names>K</given-names></name>, <name><surname>Patel</surname><given-names>N</given-names></name>, <name><surname>Jain</surname><given-names>M</given-names></name>, <name><surname>El-Amm</surname><given-names>J</given-names></name>, <name><surname>Amro</surname><given-names>F</given-names></name>, <name><surname>Tabbara</surname><given-names>IA</given-names></name>. <article-title>Complications of allogeneic hematopoietic stem cell transplantation</article-title>. <source>Cancer Invest</source>. <year>2014</year>;<volume>32</volume>: <fpage>349</fpage>–<lpage>362</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3109/07357907.2014.919301</pub-id>
<?supplied-pmid 24902046?><pub-id pub-id-type="pmid">24902046</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Applebaum</surname><given-names>AJ</given-names></name>, <name><surname>Bevans</surname><given-names>M</given-names></name>, <name><surname>Son</surname><given-names>T</given-names></name>, <name><surname>Evans</surname><given-names>K</given-names></name>, <name><surname>Hernandez</surname><given-names>M</given-names></name>, <name><surname>Giralt</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>A scoping review of caregiver burden during allogeneic HSCT: lessons learned and future directions</article-title>. <source>Bone Marrow Transplant</source>. <year>2016</year>;<volume>51</volume>(<issue>11</issue>): <fpage>1416</fpage>–<lpage>1422</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1038/bmt.2016.164</pub-id>
<?supplied-pmid 27295270?><pub-id pub-id-type="pmid">27295270</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Xie</surname><given-names>L</given-names></name>, <name><surname>Shen</surname><given-names>C</given-names></name>, <name><surname>Shi</surname><given-names>Y</given-names></name>, <name><surname>Li</surname><given-names>H</given-names></name>. <article-title>Caregiver burden among primary family caregivers of patients undergoing HSCT: a cross-sectional study from Suzhou</article-title>, <source>China. Cancer Nurs</source>. <year>2021</year>;<volume>44</volume>(<issue>6</issue>): <fpage>E556</fpage>–<lpage>E566</lpage>.<pub-id pub-id-type="pmid">32976183</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>V</given-names></name>, <name><surname>Raj</surname><given-names>M</given-names></name>, <name><surname>Hoodin</surname><given-names>F</given-names></name>, <name><surname>Yahng</surname><given-names>L</given-names></name>, <name><surname>Braun</surname><given-names>T</given-names></name>, <name><surname>Choi</surname><given-names>SW</given-names></name>. <article-title>Electronic health record portal use by family caregivers of patients undergoing HSCT: United States national survey study</article-title>. <source>JMIR Cancer</source>. <year>2021</year>;<volume>7</volume>(<issue>1</issue>): <fpage>e26509</fpage>.<pub-id pub-id-type="pmid">33687332</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Ravyts</surname><given-names>SG</given-names></name>, <name><surname>Sannes</surname><given-names>TS</given-names></name>, <name><surname>Dzierzewski</surname><given-names>JM</given-names></name>, <name><surname>Zhou</surname><given-names>ES</given-names></name>, <name><surname>Brewer</surname><given-names>BW</given-names></name>, <name><surname>Natvig</surname><given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Check your sleep before you start: a secondary analysis of a stress management intervention for caregivers of stem cell transplant patients</article-title>. <source>Psychooncology</source>. <year>2021</year>;<volume>30</volume>(<issue>6</issue>): <fpage>936</fpage>–<lpage>945</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pon.5680</pub-id>
<?supplied-pmid 33749066?><pub-id pub-id-type="pmid">33749066</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Ahn</surname><given-names>S</given-names></name>, <name><surname>Esquivel</surname><given-names>JH</given-names></name>, <name><surname>Davis</surname><given-names>EM</given-names></name>, <name><surname>Logan</surname><given-names>JG</given-names></name>, <name><surname>Chung</surname><given-names>ML</given-names></name>. <article-title>Cardiovascular disease incidence and risk in family caregivers of adults with chronic conditions: a systematic review</article-title>. <source>J Cardiovasc Nurs</source>. <year>2022</year>;<volume>37</volume>(<issue>3</issue>): <fpage>E47</fpage>–<lpage>E60</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1097/JCN.0000000000000816</pub-id>
<?supplied-pmid 33938535?><pub-id pub-id-type="pmid">33938535</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Carver</surname><given-names>CS</given-names></name>, <name><surname>Shaffer</surname><given-names>KM</given-names></name>, <name><surname>Gansler</surname><given-names>T</given-names></name>, <name><surname>Cannady</surname><given-names>RS</given-names></name>. <article-title>Cancer caregiving predicts physical impairments: roles of earlier caregiving stress and being a spousal caregiver</article-title>. <source>Cancer</source>. <year>2015</year>;<volume>121</volume>(<issue>2</issue>): <fpage>302</fpage>–<lpage>310</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/cncr.29040</pub-id>
<?supplied-pmid 25209592?><pub-id pub-id-type="pmid">25209592</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Lee</surname><given-names>LJ</given-names></name>, <name><surname>Kim</surname><given-names>Y</given-names></name>, <name><surname>Shamburek</surname><given-names>R</given-names></name>, <name><surname>Ross</surname><given-names>A</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Bevans</surname><given-names>MF</given-names></name>. <article-title>Caregiving stress and burden associated with cardiometabolic risk in family caregivers of individuals with cancer</article-title>. <source>Stress</source>. <year>2022</year>;<volume>25</volume>(<issue>1</issue>): <fpage>258</fpage>–<lpage>266</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1080/10253890.2022.2037548</pub-id>
<?supplied-pmid 35727023?><pub-id pub-id-type="pmid">35727023</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Steel</surname><given-names>JL</given-names></name>, <name><surname>Cheng</surname><given-names>H</given-names></name>, <name><surname>Pathak</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Miceli</surname><given-names>J</given-names></name>, <name><surname>Hecht</surname><given-names>CL</given-names></name>, <etal>et al</etal>. <article-title>Psychosocial and behavioral pathways of metabolic syndrome in cancer caregivers</article-title>. <source>Psychooncology</source>. <year>2019</year>;<volume>28</volume>(<issue>8</issue>): <fpage>1735</fpage>–<lpage>1742</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pon.5147</pub-id>
<?supplied-pmid 31206896?><pub-id pub-id-type="pmid">31206896</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Johns</surname><given-names>SA</given-names></name>, <name><surname>Beck-Coon</surname><given-names>K</given-names></name>, <name><surname>Stutz</surname><given-names>PV</given-names></name>, <name><surname>Talib</surname><given-names>TL</given-names></name>, <name><surname>Chinh</surname><given-names>K</given-names></name>, <name><surname>Cottingham</surname><given-names>AH</given-names></name>, <etal>et al</etal>. <article-title>Mindfulness training supports quality of life and advance care planning in adults with metastatic cancer and their caregivers: results of a pilot study</article-title>. <source>Am J Hosp Palliat Care</source>. <year>2020</year>;<volume>37</volume>(<issue>2</issue>): <fpage>88</fpage>–<lpage>99</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1177/1049909119862254</pub-id>
<?supplied-pmid 31378080?><pub-id pub-id-type="pmid">31378080</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Schellekens</surname><given-names>MPJ</given-names></name>, <name><surname>van den Hurk</surname><given-names>DGM</given-names></name>, <name><surname>Prins</surname><given-names>JB</given-names></name>, <name><surname>Donders</surname><given-names>ART</given-names></name>, <name><surname>Molema</surname><given-names>J</given-names></name>, <name><surname>Dekhuijzen</surname><given-names>R</given-names></name>, <etal>et al</etal>. <article-title>Mindfulness-based stress reduction added to care as usual for lung cancer patients and/or their partners: a multicentre randomized controlled trial</article-title>. <source>Psychooncology</source>. <year>2017</year>;<volume>26</volume>(<issue>12</issue>): <fpage>2118</fpage>–<lpage>2126</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pon.4430</pub-id>
<?supplied-pmid 28337821?><pub-id pub-id-type="pmid">28337821</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Milbury</surname><given-names>K</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Weathers</surname><given-names>S-P</given-names></name>, <name><surname>Mallaiah</surname><given-names>S</given-names></name>, <name><surname>Armstrong</surname><given-names>T</given-names></name>, <name><surname>Li</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers</article-title>. <source>Neurooncol Pract</source>. <year>2019</year>;<volume>6</volume>(<issue>4</issue>): <fpage>311</fpage>–<lpage>320</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/nop/npy052</pub-id>
<?supplied-pmid 31386042?><pub-id pub-id-type="pmid">31386042</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Vinci</surname><given-names>C</given-names></name>, <name><surname>Pidala</surname><given-names>J</given-names></name>, <name><surname>Lau</surname><given-names>P</given-names></name>, <name><surname>Reblin</surname><given-names>M</given-names></name>, <name><surname>Jim</surname><given-names>H</given-names></name>. <article-title>A mindfulness-based intervention for caregivers of allogeneic hematopoietic stem cell transplant patients: pilot results</article-title>. <source>Psychooncology</source>. <year>2020</year>;<volume>29</volume>(<issue>5</issue>): <fpage>934</fpage>–<lpage>937</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/pon.5353</pub-id>
<?supplied-pmid 32043667?><pub-id pub-id-type="pmid">32043667</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Park</surname><given-names>J</given-names></name>, <name><surname>Ross</surname><given-names>A</given-names></name>, <name><surname>Klagholz</surname><given-names>SD</given-names></name>, <name><surname>Bevans</surname><given-names>MF</given-names></name>. <article-title>The role of biomarkers in research on caregivers of cancer patients: a scoping review</article-title>. <source>Biol Res Nurs</source>. <year>2018</year>;<volume>20</volume>(<issue>3</issue>): <fpage>300</fpage>–<lpage>311</lpage>.<pub-id pub-id-type="pmid">29130313</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref017">
                <label>17</label>
                <mixed-citation publication-type="book"><name><surname>Franke</surname><given-names>DDH</given-names></name>, <name><surname>Connelly</surname><given-names>MA</given-names></name>. <part-title>Chapter 11—Nuclear magnetic resonance technology and clinical applications</part-title>. In: <name><surname>Clarke</surname><given-names>W</given-names></name>, <name><surname>Marzinke</surname><given-names>MA</given-names></name>, editors. <source>Contemporary practice in clinical chemistry</source>. <edition designator="4">4th ed</edition>. <publisher-name>Academic Press</publisher-name>; <year>2020</year>. pp. <fpage>187</fpage>–<lpage>200</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0277009.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Otvos</surname><given-names>JD</given-names></name>, <name><surname>Mora</surname><given-names>S</given-names></name>, <name><surname>Shalaurova</surname><given-names>I</given-names></name>, <name><surname>Greenland</surname><given-names>P</given-names></name>, <name><surname>Mackey</surname><given-names>RH</given-names></name>, <name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name>. <article-title>Clinical implications of discordance between low-density lipoprotein cholesterol and particle number</article-title>. <source>J Clin Lipidol</source>. <year>2011</year>;<volume>5</volume>(<issue>2</issue>): <fpage>105</fpage>–<lpage>113</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jacl.2011.02.001</pub-id>
<?supplied-pmid 21392724?><pub-id pub-id-type="pmid">21392724</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Matyus</surname><given-names>SP</given-names></name>, <name><surname>Braun</surname><given-names>PJ</given-names></name>, <name><surname>Wolak-Dinsmore</surname><given-names>J</given-names></name>, <name><surname>Jeyarajah</surname><given-names>EJ</given-names></name>, <name><surname>Shalaurova</surname><given-names>I</given-names></name>, <name><surname>Xu</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>NMR measurement of LDL particle using the Vantera Clinical Analyzer</article-title>. <source>Clin Biochem</source>. <year>2014</year>;<volume>47</volume>(<issue>16–17</issue>): <fpage>203</fpage>–<lpage>210</lpage>.<pub-id pub-id-type="pmid">25079243</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Urbina</surname><given-names>EM</given-names></name>, <name><surname>McCoy</surname><given-names>CE</given-names></name>, <name><surname>Gao</surname><given-names>Z</given-names></name>, <name><surname>Khoury</surname><given-names>PR</given-names></name>, <name><surname>Shah</surname><given-names>AS</given-names></name>, <name><surname>Dolan</surname><given-names>LM</given-names></name>, <etal>et al</etal>. <article-title>Lipoprotein particle number and size predict vascular structure and function better than traditional lipids in adolescent and young adults</article-title>. <source>J Clin Lipidol</source>, <year>2017</year>;<volume>11</volume>(<issue>4</issue>): <fpage>1023</fpage>–<lpage>1031</lpage>.<pub-id pub-id-type="pmid">28826565</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>A</given-names></name>, <name><surname>Shamburek</surname><given-names>R</given-names></name>, <name><surname>Wehrlen</surname><given-names>L</given-names></name>, <name><surname>Klagholz</surname><given-names>SD</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Stoops</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>Cardiometabolic risk factors and health behaviors in family caregivers</article-title>. <source>PLoS One</source>. <year>2017</year>;<volume>12</volume>(<issue>5</issue>): <fpage>e0176408</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1371/journal.pone.0176408</pub-id><?supplied-pmid 28472106?><pub-id pub-id-type="pmid">28472106</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref022">
                <label>22</label>
                <mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>A</given-names></name>, <name><surname>Lee</surname><given-names>LJ</given-names></name>, <name><surname>Wehrlen</surname><given-names>L</given-names></name>, <name><surname>Cox</surname><given-names>R</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Perez</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Factors that influence health-promoting behaviors in cancer caregivers</article-title>. <source>Oncol Nurs Forum</source>, <year>2020</year>;<volume>47</volume>(<issue>6</issue>): <fpage>692</fpage>–<lpage>702</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1188/20.ONF.692-702</pub-id>
<?supplied-pmid 33063787?><pub-id pub-id-type="pmid">33063787</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Mochari-Greenberger</surname><given-names>H</given-names></name>, <name><surname>Mosca</surname><given-names>L</given-names></name>. <article-title>Caregiver burden and nonachievement of health lifestyle behaviors among family caregivers of cardiovascular disease patients</article-title>. <source>Am J Health Promot</source>. <year>2012</year>;<volume>27</volume>(<issue>2</issue>): <fpage>84</fpage>–<lpage>89</lpage>.<pub-id pub-id-type="pmid">23113777</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Sisk</surname><given-names>RJ</given-names></name>. <article-title>Caregiver burden and health promotion</article-title>. <source>Int J Nurs Stud</source>. <year>2000</year>;<volume>37</volume>(<issue>1</issue>): <fpage>37</fpage>–<lpage>43</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/s0020-7489(99)00053-x</pub-id>
<?supplied-pmid 10687808?><pub-id pub-id-type="pmid">10687808</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Cramer</surname><given-names>H</given-names></name>, <name><surname>Ward</surname><given-names>L</given-names></name>, <name><surname>Saper</surname><given-names>R</given-names></name>, <name><surname>Fishbein</surname><given-names>D</given-names></name>, <name><surname>Dobos</surname><given-names>G</given-names></name>, <name><surname>Lauche</surname><given-names>R</given-names></name>. <article-title>The safety of yoga: a systematic review and meta-analysis of randomized controlled trials</article-title>. <source>Am J Epidemiol</source>. <year>2015</year>;<volume>182</volume>(<issue>4</issue>): <fpage>281</fpage>–<lpage>293</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1093/aje/kwv071</pub-id>
<?supplied-pmid 26116216?><pub-id pub-id-type="pmid">26116216</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Cohen</surname><given-names>S</given-names></name>, <name><surname>Janicki‐Deverts</surname><given-names>D</given-names></name>. <article-title>Who’s stressed? Distributions of psychological stress in the United States in probability samples from 1983, 2006, and 2009</article-title>. <source>J Appl Soc Psychol</source>. <year>2012</year>;<volume>42</volume>(<issue>6</issue>): <fpage>1320</fpage>–<lpage>1334</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0277009.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Gershon</surname><given-names>RC</given-names></name>, <name><surname>Wagster</surname><given-names>MV</given-names></name>, <name><surname>Hendrie</surname><given-names>HC</given-names></name>, <name><surname>Fox</surname><given-names>NA</given-names></name>, <name><surname>Cook</surname><given-names>KF</given-names></name>, <name><surname>Nowinski</surname><given-names>CJ</given-names></name>. <article-title>NIH toolbox for assessment of neurological and behavioral function</article-title>. <source>Neurology</source>. <year>2013</year>;<volume>80</volume>(<issue>11 Suppl 3</issue>):<fpage>S2</fpage>–<lpage>S6</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1212/WNL.0b013e3182872e5f</pub-id>
<?supplied-pmid 23479538?><pub-id pub-id-type="pmid">23479538</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Cella</surname><given-names>D</given-names></name>, <name><surname>Riley</surname><given-names>W</given-names></name>, <name><surname>Stone</surname><given-names>A</given-names></name>, <name><surname>Rothrock</surname><given-names>N</given-names></name>, <name><surname>Reeve</surname><given-names>B</given-names></name>, <name><surname>Yount</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008</article-title>. <source>J Clin Epidemiol</source>. <year>2010</year>;<volume>63</volume>(<issue>11</issue>): <fpage>1179</fpage>–<lpage>1194</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jclinepi.2010.04.011</pub-id>
<?supplied-pmid 20685078?><pub-id pub-id-type="pmid">20685078</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Bevans</surname><given-names>MF</given-names></name>, <name><surname>Ross</surname><given-names>A</given-names></name>, <name><surname>Wehrlen</surname><given-names>L</given-names></name>, <name><surname>Klagholz</surname><given-names>SD</given-names></name>, <name><surname>Yang</surname><given-names>L</given-names></name>, <name><surname>Childs</surname><given-names>R</given-names></name>, <etal>et al</etal>. <source>Documenting stress in caregivers of transplantation patients: initial evidence of HPA dysregulation</source>. <year>2016</year>;<volume>19</volume>(<issue>2</issue>): <fpage>175</fpage>–<lpage>184</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0277009.ref030">
                <label>30</label>
                <mixed-citation publication-type="other">Fitzmaurice GM, Laird NM, Ware JH. Applied longitudinal analysis. 2<sup>nd</sup> Edition. John Wiley &amp; Sons; 2011. Chapter 20, Sample size and power for longitudinal studies; p. 581–609.</mixed-citation>
              </ref>
              <ref id="pone.0277009.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Bernardi</surname><given-names>MLD</given-names></name>, <name><surname>Amorim</surname><given-names>MHC</given-names></name>, <name><surname>Salaroli</surname><given-names>LB</given-names></name>, <name><surname>Zandonade</surname><given-names>E</given-names></name>. <article-title>Effects of Hatha Yoga on caregivers of children and adolescents with cancer: a randomized controlled trial</article-title>. <source>Esc Anna Nery</source>. <year>2019</year>;<volume>24</volume>(<issue>1</issue>): <fpage>e20190133</fpage>.</mixed-citation>
              </ref>
              <ref id="pone.0277009.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Cheung</surname><given-names>DSK</given-names></name>, <name><surname>Kor</surname><given-names>PPK</given-names></name>, <name><surname>Jones</surname><given-names>C</given-names></name>, <name><surname>Davies</surname><given-names>N</given-names></name>, <name><surname>Moyle</surname><given-names>W</given-names></name>, <name><surname>Chien</surname><given-names>WT</given-names></name>, <etal>et al</etal>. <article-title>The use of modified mindfulness-based stress reduction and mindfulness-based cognitive therapy program for family caregivers of people living with dementia: a feasibility study</article-title>. <source>Asian Nurs Res (Korean Soc Nurs Sci)</source>. <year>2020</year>;<volume>14</volume>(<issue>4</issue>): <fpage>221</fpage>–<lpage>230</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.anr.2020.08.009</pub-id>
<?supplied-pmid 32931996?><pub-id pub-id-type="pmid">32931996</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Danucalov</surname><given-names>MAD</given-names></name>, <name><surname>Kozasa</surname><given-names>EH</given-names></name>, <name><surname>Ribas</surname><given-names>KT</given-names></name>, <name><surname>Galduróz</surname><given-names>JCF</given-names></name>, <name><surname>Garcia</surname><given-names>MC</given-names></name>, <name><surname>Verreschi</surname><given-names>ITN</given-names></name>, <etal>et al</etal>. <article-title>A yoga and compassion meditation program reduces stress in familial caregivers of Alzheimer’s disease patients</article-title>. <source>Evid Based Complement Alternat Med</source>. <year>2013</year>;<volume>2013</volume>: <fpage>513149</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1155/2013/513149</pub-id><?supplied-pmid 23690846?><pub-id pub-id-type="pmid">23690846</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Varambally</surname><given-names>S</given-names></name>, <name><surname>Vidyendaran</surname><given-names>S</given-names></name>, <name><surname>Sajjanar</surname><given-names>M</given-names></name>, <name><surname>Thirthalli</surname><given-names>J</given-names></name>, <name><surname>Hamza</surname><given-names>A</given-names></name>, <name><surname>Nagendra</surname><given-names>HR</given-names></name>, <etal>et al</etal>. <article-title>Yoga-based intervention for caregivers of outpatients with psychosis: a randomized controlled pilot study</article-title>. <source>Asian J Psychiatr</source>. <year>2013</year>;<volume>6</volume>(<issue>2</issue>): <fpage>141</fpage>–<lpage>145</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.ajp.2012.09.017</pub-id>
<?supplied-pmid 23466111?><pub-id pub-id-type="pmid">23466111</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Butzer</surname><given-names>B</given-names></name>, <name><surname>LoRusso</surname><given-names>A</given-names></name>, <name><surname>Shin</surname><given-names>SH</given-names></name>, <name><surname>Khalsa</surname><given-names>SBS</given-names></name>. <article-title>Evaluation of yoga for preventing adolescent substance use risk factors in a middle school setting: a preliminary group-randomized controlled trial</article-title>. <source>J Youth Adolesc</source>. <year>2017</year>;<volume>46</volume>(<issue>3</issue>): <fpage>603</fpage>–<lpage>632</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1007/s10964-016-0513-3</pub-id>
<?supplied-pmid 27246653?><pub-id pub-id-type="pmid">27246653</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Chong</surname><given-names>CSM</given-names></name>, <name><surname>Tsunaka</surname><given-names>M</given-names></name>, <name><surname>Tsang</surname><given-names>HWH</given-names></name>, <name><surname>Chan</surname><given-names>EP</given-names></name>, <name><surname>Cheung</surname><given-names>WM</given-names></name>. <article-title>Effects of yoga on stress management in healthy adults: a systematic review</article-title>. <source>Altern Ther Health Med</source>. <year>2011</year>;<volume>17</volume>(<issue>1</issue>): <fpage>32</fpage>–<lpage>38</lpage>. <?supplied-pmid 21614942?><pub-id pub-id-type="pmid">21614942</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>F</given-names></name>, <name><surname>Szabo</surname><given-names>A</given-names></name>. <article-title>Effects of yoga on stress among healthy adults: a systematic review</article-title>. <source>Altern Ther Health Med</source>. <year>2020</year>;<volume>26</volume>(<issue>4</issue>): <fpage>AT6214</fpage>. <?supplied-pmid 32088671?><pub-id pub-id-type="pmid">32088671</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Adeva-Andany</surname><given-names>MM</given-names></name>, <name><surname>Martínez-Rodríguez</surname><given-names>J</given-names></name>, <name><surname>González-Lucán</surname><given-names>M</given-names></name>, <name><surname>Fernández-Fernández</surname><given-names>C</given-names></name>, <name><surname>Castro-Quintela</surname><given-names>E</given-names></name>. <article-title>Insulin resistance is a cardiovascular risk factor in humans</article-title>. <source>Diabetes Metab Syndr</source>. <year>2019</year>;<volume>13</volume>(<issue>2</issue>): <fpage>1449</fpage>–<lpage>1455</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.dsx.2019.02.023</pub-id>
<?supplied-pmid 31336505?><pub-id pub-id-type="pmid">31336505</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Schmiegelow</surname><given-names>MD</given-names></name>, <name><surname>Hedlin</surname><given-names>H</given-names></name>, <name><surname>Stefanick</surname><given-names>ML</given-names></name>, <name><surname>Mackey</surname><given-names>RH</given-names></name>, <name><surname>Allison</surname><given-names>M</given-names></name>, <name><surname>Martin</surname><given-names>LW</given-names></name>, <etal>et al</etal>. <article-title>Insulin resistance and risk of cardiovascular disease in postmenopausal women: a cohort study from the Women’s Health Initiative</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>. <year>2015</year>;<volume>8</volume>(<issue>3</issue>): <fpage>309</fpage>–<lpage>316</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/CIRCOUTCOMES.114.001563</pub-id>
<?supplied-pmid 25944628?><pub-id pub-id-type="pmid">25944628</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Thacker</surname><given-names>EL</given-names></name>, <name><surname>Psaty</surname><given-names>BM</given-names></name>, <name><surname>McKnight</surname><given-names>B</given-names></name>, <name><surname>Heckbert</surname><given-names>SR</given-names></name>, <name><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></name>, <name><surname>Mukamal</surname><given-names>KJ</given-names></name>, <etal>et al</etal>. <article-title>Fasting and post-glucose load measures of insulin resistance and risk of ischemic stroke in older adults</article-title>. <source>Stroke</source>. <year>2011</year>;<volume>42</volume>(<issue>12</issue>): <fpage>3347</fpage>–<lpage>3351</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.620773</pub-id>
<?supplied-pmid 21998054?><pub-id pub-id-type="pmid">21998054</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Garvey</surname><given-names>WT</given-names></name>, <name><surname>Kwon</surname><given-names>S</given-names></name>, <name><surname>Zheng</surname><given-names>D</given-names></name>, <name><surname>Shaughnessy</surname><given-names>S</given-names></name>, <name><surname>Wallace</surname><given-names>P</given-names></name>, <name><surname>Hutto</surname><given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance</article-title>. <source>Diabetes</source>. <year>2003</year>;<volume>52</volume>(<issue>2</issue>): <fpage>453</fpage>–<lpage>462</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.2337/diabetes.52.2.453</pub-id>
<?supplied-pmid 12540621?><pub-id pub-id-type="pmid">12540621</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Goff</surname><given-names>DC</given-names><suffix>Jr</suffix></name>, <name><surname>D’Agostino</surname><given-names>RB</given-names><suffix>Jr</suffix></name>, <name><surname>Haffner</surname><given-names>SM</given-names></name>, <name><surname>Otvos</surname><given-names>JD</given-names></name>. <article-title>Insulin resistance and adiposity influence lipoprotein size and subclass concentrations. Results from the Insulin Resistance Atherosclerosis Study</article-title>. <source>Metabolism</source>. <year>2005</year>;<volume>54</volume>(<issue>2</issue>): <fpage>264</fpage>–<lpage>270</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.metabol.2004.09.002</pub-id>
<?supplied-pmid 15690322?><pub-id pub-id-type="pmid">15690322</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref043">
                <label>43</label>
                <mixed-citation publication-type="journal"><name><surname>Goldberg</surname><given-names>IJ</given-names></name>. <article-title>Clinical review 124: Diabetic dyslipidemia: causes and consequences</article-title>. <source>J Clin Endocrinol Metab</source>. <year>2001</year>;<volume>86</volume>(<issue>3</issue>): <fpage>965</fpage>–<lpage>971</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1210/jcem.86.3.7304</pub-id>
<?supplied-pmid 11238470?><pub-id pub-id-type="pmid">11238470</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref044">
                <label>44</label>
                <mixed-citation publication-type="journal"><name><surname>Peckett</surname><given-names>AJ</given-names></name>, <name><surname>Wright</surname><given-names>DC</given-names></name>, <name><surname>Riddell</surname><given-names>MC</given-names></name>. <article-title>The effects of glucocorticoids on adipose tissue lipid metabolism</article-title>. <source>Metabolism</source>. <year>2011</year>;<volume>60</volume>(<issue>11</issue>): <fpage>1500</fpage>–<lpage>1510</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.metabol.2011.06.012</pub-id>
<?supplied-pmid 21864867?><pub-id pub-id-type="pmid">21864867</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Harada</surname><given-names>PHN</given-names></name>, <name><surname>Demler</surname><given-names>OV</given-names></name>, <name><surname>Dugani</surname><given-names>SB</given-names></name>, <name><surname>Akinkuolie</surname><given-names>AO</given-names></name>, <name><surname>Moorthy</surname><given-names>MV</given-names></name>, <name><surname>Ridker</surname><given-names>PM</given-names></name>, <etal>et al</etal>. <article-title>Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women’s Health Study</article-title>. <source>J Clin Lipidol</source>. <year>2017</year>;<volume>11</volume>(<issue>5</issue>): <fpage>1257</fpage>–<lpage>1267</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jacl.2017.06.008</pub-id>
<?supplied-pmid 28733174?><pub-id pub-id-type="pmid">28733174</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref046">
                <label>46</label>
                <mixed-citation publication-type="journal"><name><surname>Flores-Guerrero</surname><given-names>JL</given-names></name>, <name><surname>Connelly</surname><given-names>MA</given-names></name>, <name><surname>Shalaurova</surname><given-names>I</given-names></name>, <name><surname>Gruppen</surname><given-names>EG</given-names></name>, <name><surname>Kieneker</surname><given-names>LM</given-names></name>, <name><surname>Dullaart</surname><given-names>RPF</given-names></name>, <etal>et al</etal>. <article-title>Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study</article-title>. <source>J Clin Lipidol</source>. <year>2019</year>;<volume>13</volume>(<issue>1</issue>): <fpage>129</fpage>–<lpage>137.e1</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1016/j.jacl.2018.11.009</pub-id>
<?supplied-pmid 30591414?><pub-id pub-id-type="pmid">30591414</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Flores-Guerrero</surname><given-names>JL</given-names></name>, <name><surname>Gruppen</surname><given-names>EG</given-names></name>, <name><surname>Connelly</surname><given-names>MA</given-names></name>, <name><surname>Shalaurova</surname><given-names>I</given-names></name>, <name><surname>Otvos</surname><given-names>JD</given-names></name>, <name><surname>Garcia</surname><given-names>E</given-names></name>, <etal>et al</etal>. <article-title>A newly developed diabetes risk index, based on lipoprotein subfractions and branched chain amino acids, is associated with incident type 2 diabetes mellitus in the PREVEND Cohort</article-title>. <source>J Clin Med</source>. <year>2020</year>;<volume>9</volume>(<issue>9</issue>): <fpage>2781</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3390/jcm9092781</pub-id><?supplied-pmid 32867285?><pub-id pub-id-type="pmid">32867285</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Ellsworth</surname><given-names>DL</given-names></name>, <name><surname>Costantino</surname><given-names>NS</given-names></name>, <name><surname>Blackburn</surname><given-names>HL</given-names></name>, <name><surname>Engler</surname><given-names>RJM</given-names></name>, <name><surname>Kashani</surname><given-names>M</given-names></name>, <name><surname>Vernalis</surname><given-names>MN</given-names></name>. <article-title>Lifestyle modification interventions differing in intensity and dietary stringency improve insulin resistance through changes in lipoprotein profiles</article-title>. <source>Obes Sci Pract</source>. <year>2016</year>;<volume>2</volume>(<issue>3</issue>): <fpage>282</fpage>–<lpage>292</lpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.1002/osp4.54</pub-id>
<?supplied-pmid 27708845?><pub-id pub-id-type="pmid">27708845</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0277009.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Ross</surname><given-names>LM</given-names></name>, <name><surname>Slentz</surname><given-names>CA</given-names></name>, <name><surname>Zidek</surname><given-names>AM</given-names></name>, <name><surname>Huffman</surname><given-names>KM</given-names></name>, <name><surname>Shalaurova</surname><given-names>I</given-names></name>, <name><surname>Otvos</surname><given-names>JD</given-names></name>, <etal>et al</etal>. <article-title>Effects of amount, intensity, and mode of exercise training on insulin resistance and type 2 diabetes risk in the STRRIDE randomized trials</article-title>. <source>Front Physiol</source>. <year>2021</year>;<volume>12</volume>: <fpage>626142</fpage>. <comment>doi: </comment><pub-id pub-id-type="doi">10.3389/fphys.2021.626142</pub-id><?supplied-pmid 33613319?><pub-id pub-id-type="pmid">33613319</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
